LabCorp (LH)
LH Stock Price Chart
Key Info
| Market Cap | 19.37B |
| Revenue (ttm) | 12.44B |
| Net Income (ttm) | 844.90M |
| Shares Out | 97.40M |
| EPS (ttm) | 8.62 |
| PE Ratio | 23.06 |
| Forward PE | 11.85 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | December 4 |
| Last Price | $198.85 |
| Previous Close | $196.64 |
| Change ($) | 2.21 |
| Change (%) | 1.12% |
| Day's Open | 197.00 |
| Day's Range | 195.87 - 199.34 |
| Day's Volume | 1,078,796 |
| 52-Week Range | 104.32 - 214.42 |
LH Stock News
LabCorp (LH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
To beat the pandemic blues and maximize capital gains, investors can now scoop up these fundamentally-strong MedTech growth stocks.
Top Ranked Growth Stocks to Buy for December 3rd
LH vs. CNMD: Which Stock Is the Better Value Option?
Here are a few coronavirus-testing MedTech stocks that investors can scoop up to reap profits amid the pandemic-battered stock market situation.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
A company that is capable of generating earnings well above its interest expense can withstand financial hardships.
Top Ranked Growth Stocks to Buy for November 27th
After a detailed study of Driehaus' strategy, AAII concluded that it mainly focuses on strong earnings growth rates and impressive prospects to pick potential outperformers.
LabCorp's (LH) Patient Direct offering will be used here to help in bringing suitable clinical trials to eligible patients directly.
Top Ranked Growth Stocks to Buy for November 25th
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that membe...
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects. Some such stocks are LH, ODP, HMC, SPB and BCC.
Top Ranked Growth Stocks to Buy for November 20th
At this stage, it makes good sense to buy those stocks on the dip that could prove to be valuable once the rally resumes. These are Office Depot (ODP), WESCO (WCC), General Motors (GM), Labora...
Laboratory Corporation Of America saw its IBD SmartSelect Composite Rating jump to 97 Thursday, up from 94 the day before. The post Lab Corp. Stock Passes Composite Rating Test With Flying Col...
LabCorp (LH) could produce exceptional returns because of its solid growth attributes.
Is (LH) Outperforming Other Medical Stocks This Year?
Top Ranked Growth Stocks to Buy for November 17th
Top Ranked Growth Stocks to Buy for November 13th
LabCorp is a mission-critical company that has been on the forefront of testing for COVID-19. I'm encouraged by the strong revenue backlog of its Covance drug development business, and by the ...
PEG-based investing can turn out to be even more rewarding if some other relevant parameters are also taken into consideration.
Laboratory Corporation Of America shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. The post Laboratory Corp. Of America Profit Nearly Triples, Flashes...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
The Virus Testing Stocks Pullback Opportunity (NASDAQ: CODX) (NASDAQ: FLGT) (OTC: ALST) (NYSE: LH)
Investors who have the propensity to take a higher risk can think of investing in momentum stocks to boost their gains.
When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
A company that is capable of generating earnings well above its interest expense can withstand financial hardships.
Cramer on four coronavirus testing stocks worth owning
"I bet the testing stocks have a lot more room to run," the "Mad Money" host said.
LabCorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Investing opportunistically in growth stocks is the way to go in volatile markets.
The Vanguard Health Care Fund (Trades, Portfolio) released its third-quarter portfolio earlier this week.
"All of these names would work under both candidates," the "Mad Money" host said ahead of the presidential election.
In this article we will take a look at whether hedge funds think Laboratory Corp. of America Holdings (NYSE:LH) is a good investment right now. We check hedge fund and billionaire investor sen...
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the 29th Annual Credit Suisse...
Does LabCorp (LH) have what it takes to be a top stock pick for momentum investors? Let's find out.
LH vs. CNMD: Which Stock Is the Better Value Option?
3 Dental Supplies Stocks Set to Shine on the Industry's Upturn
On Wednesday, Laboratory Corporation Of America got an upgrade for its IBD SmartSelect Composite Rating from 92 to 98. The post LabCorp Earns Membership In 95-Plus Composite Rating Club appear...
Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q3 2020 Results - Earnings Call Transcript
LabCorp (LH) Diagnostics business in Q3 grows significantly on organic volume improvements as a result of growing demand for COVID-19 testing.
LabCorp (LH) delivered earnings and revenue surprises of 58.98% and 4.70%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Laboratory Corp (NYSE:LH) moved higher by 0.5% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 190.00% over the past year to...
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (or the Company) (NYSE: LH) today announced results for the third quarter ended September 30, 2020. “LabCorp remains committed to fighting the pandem...
Under the extended alliance, LabCorp (LH) expects to expand its COVID-19 test capacity in the Seattle area.
LabCorp (LH) closed the most recent trading day at $203.16, moving -1% from the previous trading session.
LabCorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In Q3, LabCorp (LH) significantly expands accessibility of PCR testing to reach underserved communities.
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced new capabi...
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Swedish, the largest n...
About LH
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The compan... [Read more...]
| Industry Diagnostics & Research | Founded 1971 |
| CEO David King | Employees 70,000 |
| Stock Exchange NYSE | Ticker Symbol LH |
Financial Performance
In 2019, LabCorp's revenue was $11.55 billion, an increase of 1.95% compared to the previous year's $11.33 billion. Earnings were $823.80 million, a decrease of -6.78%.
Analyst Forecasts
The average 12-month stock price forecast for LabCorp is 245.27, which is an increase of 23.34% from the latest price.